Refine by
Hydrogels Articles & Analysis
49 news found
The HZ-PEG-HZ (1K) product is critical for applications including: l Controlled Drug Delivery Systems: Leveraging its pH-sensitive hydrazone bonds for targeted and controlled release of active pharmaceutical ingredients in specific physiological environments (e.g., tumor microenvironments, endosomes, lysosomes). l Bioconjugation and Crosslinking: Facilitating the creation of stable linkages in ...
The firm provides various microneedle technology services, such as: l Coated Microneedle Development: For drug protection and release control. l Dissolving Microneedle Development: Biological alternatives that suck up into the skin and deliver the drug payload to the surface. l Hollow Microneedle Development: Ideal for delivery of a liquid drug with a precise dose. l Hydrogel ...
By utilizing next-generation technologies such as nanoparticles, in-situ gel, hydrogel, and dendrimer, Ace Therapeutics' drug delivery systems can ensure the right amount of medication is administered at the right time, optimizing treatment outcomes and minimizing side effects. ...
"Our multi-arm PEG derivatives are widely recognized as smart cross-linkers, and they have been extensively studied for their ability to form hydrogels. These hydrogels are pivotal in medical devices, regenerative medicine, drug delivery systems, 3D cell culture, and wound healing." ...
The new technology represents a significant advancement in the field of transdermal drug delivery. The hydrogel microneedle patch consists of a patch with tiny microneedles made of hydrogel, which can deliver drugs directly into the skin. ...
In addition to phase-transition microneedles, CD Formulation has also introduced hydrogel microneedle patch technology. Hydrogel microneedles are made from a soft, water-absorbing material that swells upon contact with fluid, creating a gentle and painless insertion into the skin. ...
In biomedical applications, functional polymers are used as synthetic building blocks to design complex structures, such as nanomaterials, biological couplings, biocompatible surfaces, scaffolds, hydrogels, etc. Research hotspots of functional polymers: Polymerization methodologies, luminescent polymers, photovoltaic polymers, biorelated polymers, supramolecular polymers, ...
The report further dissects microneedle market dynamics, categorizing products into solid, hollow, coated, dissolving, and hydrogel microneedles, and applications into disease treatment, immunobiological administration, disease diagnosis, and dermatology. Notably, the report highlights emerging applications like hydrogel and disease diagnosis, currently in ...
This technology preserves spatial relationships and microstructure by forming a more permeable tissue-hydrogel mixture for deep optical inspection, which can be used for 3D mapping and identification of rare markers. ...
Microneedle Patch Technologies CD Formulation’s microneedle patch technologies encompass phase-transition microneedle patch technology, hydrogel microneedle patch technology, solid microneedle technology, hollow microneedle technology, coated microneedle technology, and dissolving microneedle technology. ...
Abstract: We previously reported the development of a novel formulation of an ultra-long-acting local anesthetic based on bupivacaine encapsulated in large multivesicular liposomes (Bupisomes) embedded in hydrogel. This formulation (Bupigel) prolonged bupivacaine release from the formulation in dissolution-like studies in vitro and analgesia in vivo in mouse, rat, and pig models. ...
Sawhney’s newest hydrogel company, Instylla Inc., founded in 2017, is addressing interventional oncology with a hydrogel-based liquid for tumor embolization, a therapy that shrinks tumors by blocking their blood supply. ...
This application was made after the surprising observation that Atelerix’s hydrogel-encapsulation technology (in the form of SwabReady™) was able to extend the shelf life of free Coronavirus samples when stored at room temperature. ...
Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced two publications that evaluated the Embrace™ Hydrogel Embolic System (HES) in preclinical porcine hemorrhage models. ...
” “The mission of Advanced BioMatrix is to enable the future of life-saving treatments, and the HyStem technology can now be more fully utilized as a tool towards accomplishing this mission,” added Bowman Bagley, Advanced BioMatrix CEO. HyStem is a patented hydrogel which mimics naturally occurring extracellular matrix, the structural network of molecules ...
It can provide drug-delivery cargos with controllable delivery profile, or active biomaterials with various of ready-to-use bio-conjugation options, and hydrogels with sol-gel transition useful for reversible encapsulation and delivery. ...
In clinical partnership with Promaxo, we look forward to optimizing clinical workflow for office-based MRI guided biopsies in our high volume practice, and to collaborating on prostate cancer treatments, including brachytherapy and post placement confirmatory scans of hydrogel with Promaxo's MRI platform.” Dr. Joseph L. Hsu, ASUI Partner added, “Given our practice ...
Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the publication of results[i] from the first-in-human clinical trial of Embrace™ Hydrogel Embolic System (HES) for the treatment of hypervascular tumors, in the Journal of Vascular and Interventional Radiology (JVIR). ...
Biomaterials available at Alfa Chemistry Materials: Biocompatible Ceramics Bioelectronic Materials Crosslinkers Hydrogels and Crosslinked Polymers Hydrophilic Polymers Hydrophobic Polymers Natural Polymers and Biopolymers Oligonucleotide Polymers and Copolymers PEG-PPG Copolymers Poly(ethylene glycol) and Poly(ethylene oxide) Biodegradable Polymers Polyamino Acids Polysaccharide ...
UroGen has developed RTGel™ reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. ...